COMMUNIQUÉS West-GlobeNewswire

BeiGene Announces Closing of $800 Million Public Offering
22/01/2018
CAMBRIDGE, Mass. and BEIJING, China, Jan. 22, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]
AveXis Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
22/01/2018
CHICAGO, Jan. 22, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ) today announced the closing of its previously announced underwritten public offering of 4,509,840 shares of its common stock at a price to the [...]
NeoChord Announces a Research Collaboration with the Skirball Center for Innovation at the Cardiovascular Research Foundation
22/01/2018
ST. LOUIS PARK, Minn., Jan. 22, 2018 (GLOBE NEWSWIRE) -- NeoChord, Inc. , a privately-held medical technology company leading the advancement of minimally invasive valve repair for degenerative mitral regurgitation (DMR [...]
Insmed Announces Proposed Public Offering of Convertible Senior Notes
22/01/2018
BRIDGEWATER, N.J., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq: INSM ) announced today that it has commenced an underwritten public offering of $300 million aggregate principal amount of convertible [...]
Harvard Bioscience To Acquire Data Sciences International and Sells Denville Scientific
22/01/2018
Reports 2018 Guidance -Conference Call and Webcast Scheduled for Tuesday, January 23 at 7:30 AM ET- HOLLISTON, Mass., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO ) (the “Company”), a [...]
Amicus Therapeutics Announces Presentations and Posters at 14th Annual WORLDSymposium™ 2018
22/01/2018
CRANBURY, N.J., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ), today announced that two oral presentations and seven posters highlighting its development programs for Lysosomal Storage Disorders [...]
Adamas Announces Proposed Public Offering of Common Stock
22/01/2018
EMERYVILLE, Calif., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that it plans to offer $85 million of its common stock in an underwritten public offering. Adamas [...]
Stemline Therapeutics Announces Proposed Public Offering of Common Stock
22/01/2018
NEW YORK, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, today announced that it intends to offer and [...]
Karen Baker named new Chief Executive Officer of PCAR/NSVRC
22/01/2018
Harrisburg, Pa., Jan. 22, 2018 (GLOBE NEWSWIRE) -- The Pennsylvania Coalition Against Rape and the National Sexual Violence Resource Center announced that Karen Baker will take the helm of the longest-standing anti- [...]
Sanofi: Disclosure of trading in own shares
22/01/2018
Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/3de123b5-b1e4-4d01-a05d-1518af5752eb
Sanofi : Déclaration des transactions sur actions propres
22/01/2018
Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/c939a6a0-971a-4ec0-827d-8f45611b3d51
DIAXONHIT renforce sa présence dans le contrôle de qualité par un partenariat avec RCPAQAP
22/01/2018
DIAXONHIT renforce sa présence dans le contrôle de qualité Signature d'un accord exclusif pour la commercialisation dans toute l'Europe de programmes d'évaluation externe de la qualité des laboratoires de biologie [...]
ProMIS Neurosciences Issues Response to Recent Market Activity
22/01/2018
TORONTO and CAMBRIDGE, Mass., Jan. 22, 2018 (GLOBE NEWSWIRE) -- At the request of IIROC ("Investment Industry Regulatory Organization of Canada"), ProMIS Neurosciences, Inc. (TSX: PMN ) (OTCQB:ARFXF) (the "Company") [...]
Allocation of Share Options
22/01/2018
NASDAQ Copenhagen Report on transactions of executives and related parties in Coloplast shares and related securities. According to the Market Abuse Regulation art. 19 Coloplast is obliged to report on the transactions [...]
Nymox Reports 5-Year Results From Prospective Randomized Controlled Prostate Cancer Study of Fexapotide Triflutate in 146 U.S. Men
22/01/2018
HASBROUCK HEIGHTS, N.J., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX ) reported today top-line 5-year results from Nymox's U.S. Study NX03-0040. Study NX03-0040 was undertaken [...]
Medibio Signs Agreement with Striiv to Accelerate Commercialisation
22/01/2018
Medibio’s proprietary technology to be integrated into Striiv’s mobile app that has 1m+ subscribers Striiv has corporate partnerships with UnitedHealth, Qualcomm Life, and Pfizer SYDNEY, Australia and MINNEAPOLIS, Jan. [...]
The Delta Companies Promotes Paul Estrada to EVP of Delta Physician Placement
22/01/2018
DALLAS, Jan. 22, 2018 (GLOBE NEWSWIRE) -- The Delta Companies (TDC), a leading staffing firm for healthcare professionals nationwide, announced that Paul Estrada has been promoted to Executive Vice President of Delta [...]
Ossur Hf :Transactions in relation to share buyback program
22/01/2018
Announcement from Össur hf. No. 5/2018 Reykjavík, 22 January 2018 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]
BioRestorative Therapies Announces the Appointment of Adam D. Bergstein as Sr. VP, Planning and Business Development
22/01/2018
MELVILLE, N.Y., Jan. 22, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today announced the [...]

Pages